Search alternatives:
de decrease » we decrease (Expand Search), _ decrease (Expand Search), nn decrease (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), nn decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 de » 2 d (Expand Search), _ de (Expand Search), i de (Expand Search)
Showing 2,161 - 2,180 results of 105,912 for search '(( 2 de decrease ) OR ( 5 ((((wt decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 1.61s Refine Results
  1. 2161
    Carpal tunnel cross-sections used to calculate morphology metrics.

    Carpal tunnel cross-sections used to calculate morphology metrics. by Drew A. Anderson (14197446)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  2. 2162
    Effects of FE and RUD wrist postures on carpal tunnel volume distribution by quartile.

    Effects of FE and RUD wrist postures on carpal tunnel volume distribution by quartile. by Drew A. Anderson (14197446)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  3. 2163
    Table_1_When and Why Did Human Brains Decrease in Size? A New Change-Point Analysis and Insights From Brain Evolution in Ants.XLSX

    Table_1_When and Why Did Human Brains Decrease in Size? A New Change-Point Analysis and Insights From Brain Evolution in Ants.XLSX by Jeremy M. DeSilva (7247009)

    Published 2021
    “…<p>Human brain size nearly quadrupled in the six million years since Homo last shared a common ancestor with chimpanzees, but human brains are thought to have decreased in volume since the end of the last Ice Age. …”
    Save to List
    Saved in:
  4. 2164
    P-Rex is required for a late phase of stimulus-evoked cerebellar LTP.

    P-Rex is required for a late phase of stimulus-evoked cerebellar LTP. by Claire Jackson (362873)

    Published 2010
    Save to List
    Saved in:
  5. 2165
    mGluR5 binding potential (BP<sub>ND</sub>) decreased in epilepsy models according to time periods after status epilepticus.

    mGluR5 binding potential (BP<sub>ND</sub>) decreased in epilepsy models according to time periods after status epilepticus. by Hongyoon Choi (541919)

    Published 2014
    “…<p>(A–C) BP<sub>ND</sub> decreased globally in acute period after status epilepticus. …”
    Save to List
    Saved in:
  6. 2166
    Heterozygous deletion of <i>ERG251-A</i> leads to a transcriptional response in filamentation regulation.

    Heterozygous deletion of <i>ERG251-A</i> leads to a transcriptional response in filamentation regulation. by Xin Zhou (54275)

    Published 2024
    Save to List
    Saved in:
  7. 2167
    Supplementary Material for: Decreased Toll-Like Receptor 2 and Toll-Like Receptor 7/8-Induced Cytokines in Parkinson's Disease Patients

    Supplementary Material for: Decreased Toll-Like Receptor 2 and Toll-Like Receptor 7/8-Induced Cytokines in Parkinson's Disease Patients by da Silva D.J. (4159168)

    Published 2016
    Save to List
    Saved in:
  8. 2168
    Results for K<sub>s</sub>/D  = 8.8 × 10<sup>−5</sup>, (a) Power, (b) Frequency, and (c) Amplitude.

    Results for K<sub>s</sub>/D  = 8.8 × 10<sup>−5</sup>, (a) Power, (b) Frequency, and (c) Amplitude. by Muhammad Hammad Bucha (21736111)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 2169
    Results for K<sub>s</sub>/D  = 5.08 × 10<sup>−4</sup>, (a) Power, (b) Frequency, and (c) Amplitude.

    Results for K<sub>s</sub>/D  = 5.08 × 10<sup>−4</sup>, (a) Power, (b) Frequency, and (c) Amplitude. by Muhammad Hammad Bucha (21736111)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 2170
    S5 Fig -

    S5 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    “…Cost-based pricing models are discussed as a possibility for cost containment. This study focuses on two drugs, pembrolizumab (Keytruda) and daratumumab (Darzalex), to explore the potential effect of indication broadening on the estimated price when using the cost-based pricing (CBP) model proposed by Uyl-de Groot and Löwenberg (2018).…”
    Save to List
    Saved in:
  11. 2171
    Activation of vMC-dDG pathway decreases the competitive advantage of fear engram cells in the dDG neuronal network and attenuates fear generalization.

    Activation of vMC-dDG pathway decreases the competitive advantage of fear engram cells in the dDG neuronal network and attenuates fear generalization. by Kun Cui (2070772)

    Published 2024
    Save to List
    Saved in:
  12. 2172
    <i>neurod1</i><sup><i>ΔUCE</i></sup> homozygous mutants display an increase of the goblet cells concomitant with a decrease of EECs.

    <i>neurod1</i><sup><i>ΔUCE</i></sup> homozygous mutants display an increase of the goblet cells concomitant with a decrease of EECs. by Anne Sophie Reuter (12239993)

    Published 2022
    Save to List
    Saved in:
  13. 2173
    One-step and multi-step growth curves each mutant and SVA-WT.

    One-step and multi-step growth curves each mutant and SVA-WT. by Hai-Fan Zhao (15990862)

    Published 2023
    Save to List
    Saved in:
  14. 2174
    Evolution of the adjusted geometric mean plasma or serum values of vitamin B<sub>6</sub> (with adjustment for sex, baseline age, plasma creatinine, tHcy and folate), folate (with adjustment for sex, baseline age, MTHFR genotype, tHcy and vitamin B<sub>6</sub> and vitamin B<sub>12</sub>), vitamin B<sub>12</sub> (with adjustment for sex, baseline age, tHcy and folate) and tHcy (with adjustment for sex, plasma creatinine, type of prevalent CVD, MTHFR genotype, vitamin B<sub>6</sub>, vitamin B<sub>12</sub> and folate) from baseline through the 4.7y of follow-up, according to supplementation group.

    Evolution of the adjusted geometric mean plasma or serum values of vitamin B<sub>6</sub> (with adjustment for sex, baseline age, plasma creatinine, tHcy and folate), folate (with a... by Leopold K. Fezeu (5309333)

    Published 2018
    Save to List
    Saved in:
  15. 2175
    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity

    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

    Published 2014
    Subjects:
    Save to List
    Saved in:
  16. 2176
    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity

    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

    Published 2014
    Subjects:
    Save to List
    Saved in:
  17. 2177
    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity

    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

    Published 2014
    Subjects:
    Save to List
    Saved in:
  18. 2178
    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity

    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

    Published 2014
    Subjects:
    Save to List
    Saved in:
  19. 2179
    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity

    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

    Published 2014
    Subjects:
    Save to List
    Saved in:
  20. 2180
    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity

    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

    Published 2014
    Subjects:
    Save to List
    Saved in:

Search Tools: